<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Value Research Online</title>
        <atom:link href="/stories/stock/44356/shasun-pharmaceuticals-ltd-amalgamation/rss" rel="self" type="application/rss+xml" />
        <link>https://www.valueresearchonline.com/</link>
        <description>RSS Feeds | Value Research</description>
        <language>en</language>
        <copyright>Copyright 2026 Value Research India Private Limited.</copyright>
        <image>
            <title>Value Research</title>
            <url>https://www.valueresearchonline.com/assets/images/valueresearchonline-desktop.png</url>
            <link>https://www.valueresearchonline.com/</link>
        </image>

        <item>
			<title>Sensex: The index which wouldn't grow up</title>
			<link>https://www.valueresearchonline.com/stories/33795/sensex-the-index-which-wouldn-t-grow-up/</link>
			<pubDate>Tue, 30 May 2017 07:17:50 +0530</pubDate>
			<category>Stockwire</category>
			<description>The median age of the Sensex constituents is on the decline, signalling the end of legacies></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/33795/sensex-the-index-which-wouldn-t-grow-up/</guid>
		</item>
    </channel>
</rss>
